GB9621373D0 - Fatty acid treatment - Google Patents

Fatty acid treatment

Info

Publication number
GB9621373D0
GB9621373D0 GBGB9621373.1A GB9621373A GB9621373D0 GB 9621373 D0 GB9621373 D0 GB 9621373D0 GB 9621373 A GB9621373 A GB 9621373A GB 9621373 D0 GB9621373 D0 GB 9621373D0
Authority
GB
United Kingdom
Prior art keywords
fatty acid
acid treatment
treatment
fatty
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9621373.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Priority to GBGB9621373.1A priority Critical patent/GB9621373D0/en
Publication of GB9621373D0 publication Critical patent/GB9621373D0/en
Priority to AU41305/97A priority patent/AU4130597A/en
Priority to PCT/GB1997/002441 priority patent/WO1998016215A1/en
Priority to ZA9708226A priority patent/ZA978226B/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB9621373.1A 1996-10-14 1996-10-14 Fatty acid treatment Pending GB9621373D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB9621373.1A GB9621373D0 (en) 1996-10-14 1996-10-14 Fatty acid treatment
AU41305/97A AU4130597A (en) 1996-10-14 1997-09-11 Use of essential fatty acids for the treatment and prevention of radiation damage to erythrocytes
PCT/GB1997/002441 WO1998016215A1 (en) 1996-10-14 1997-09-11 Use of essential fatty acids for the treatment and prevention of radiation damage to erythrocytes
ZA9708226A ZA978226B (en) 1996-10-14 1997-09-12 Fatty acid treatment.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9621373.1A GB9621373D0 (en) 1996-10-14 1996-10-14 Fatty acid treatment

Publications (1)

Publication Number Publication Date
GB9621373D0 true GB9621373D0 (en) 1996-12-04

Family

ID=10801378

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9621373.1A Pending GB9621373D0 (en) 1996-10-14 1996-10-14 Fatty acid treatment

Country Status (4)

Country Link
AU (1) AU4130597A (en)
GB (1) GB9621373D0 (en)
WO (1) WO1998016215A1 (en)
ZA (1) ZA978226B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1220669A4 (en) * 1999-10-13 2004-12-08 Marco A Chacon Therapeutic intervention to mimic the effect of caloric restriction
US20020188024A1 (en) * 2000-08-23 2002-12-12 Chilton Floyd H. Fatty acid-containing emulsion with increased bioavailability
US8092839B2 (en) 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
US8431165B2 (en) 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
BR112013000108B1 (en) 2010-07-22 2021-05-11 Unilever Ip Holdings B.V. detergent composition, its uses, and process for cleaning a substrate
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
EP3692986A1 (en) 2014-06-04 2020-08-12 DS Biopharma Limited Pharmaceutical compositions comprising dgla and use of same
CN108741081A (en) * 2018-06-29 2018-11-06 许昌元化生物科技有限公司 One kind containing linolenic composite micro-powder and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58180423A (en) * 1982-04-16 1983-10-21 Nippon Suisan Kaisha Ltd Remedy for peripheral blood stream disorder
GB8920228D0 (en) * 1989-09-07 1989-10-18 Efamol Holdings Fatty acid therapy
GB9301446D0 (en) * 1993-01-26 1993-03-17 Scotia Holdings Plc Internal radiation damage

Also Published As

Publication number Publication date
ZA978226B (en) 1998-05-11
WO1998016215A1 (en) 1998-04-23
AU4130597A (en) 1998-05-11

Similar Documents

Publication Publication Date Title
GB9618420D0 (en) Fatty acid treatment
GB9403857D0 (en) Fatty acid derivatives
GB9411080D0 (en) Treatment
GB9112052D0 (en) Fatty acid treatment
PL332553A1 (en) 3-alkooxyisooxazol-4-yl-substituted 2-aminocarboxylic acids
GB9621373D0 (en) Fatty acid treatment
GB9619492D0 (en) Novel treatment
AU3176595A (en) Fatty acid treatment
GB9615767D0 (en) Novel treatment
GB9608657D0 (en) Novel treatment
GB9407616D0 (en) Dice
GB9626062D0 (en) Fatty acid treatment
ZA957903B (en) Fatty acid treatment
GB9515185D0 (en) Fatty acid treatment
GB9625795D0 (en) Novel treatment
GB9612752D0 (en) Novel treatment
GB9605166D0 (en) Acid treatment process
GB9605167D0 (en) Acid treatment process
GB9700383D0 (en) Fatty acid treatent
KR0137670B1 (en) 5-METHYL-5-0-(Ñß-D-GLUCOPYRANOSYL)-D-ERYTHROASCORBIC ACID
SG28202A1 (en) Fatty acid derivatives
GB9618543D0 (en) Fatty acid analogues
KR0137624B1 (en) 5-METHYL-5-0(Ñß-D-ZYLOPYRANOSYL)-D-ERYTHROASCORBIC ACID
GB9617762D0 (en) Treatment
GB9625201D0 (en) Novel treatment